Key result
Radical nephrectomy and thrombectomy in patients with renal cell carcinoma and inferior vena cava tumor thrombus achieved a 5-year cancer-specific survival of 33.1%.
Why the study?
What are the clinical and oncological outcomes of radical nephrectomy and thrombectomy in patients with renal cell carcinoma and inferior vena cava tumor thrombus?
Population
50 patients with renal cell carcinoma and tumor thrombus involving the inferior vena cava, median age 65…
Design
Cohort
Follow-up
median 26 months
Authors
Loading...
May support aggressive surgery in select advanced RCC cases; leaves open optimal selection and adjuvant strategies.
Cohort (n=50)
No
What are the clinical and oncological outcomes of radical nephrectomy and thrombectomy in patients with renal cell carcinoma and inferior vena cava tumor thrombus?
An aggressive surgical approach including nephrectomy and thrombectomy offers reasonable long-term survival in patients with RCC and IVC tumor thrombus, with distant metastasis, lymph node invasion, and grading being key prognostic factors.
Vergho et al. (2012) conducted a cohort in Renal cell carcinoma with tumor thrombus of the inferior vena cava (n=50). Radical nephrectomy and thrombectomy was evaluated on 5-year cancer-specific survival. Radical nephrectomy and thrombectomy in patients with renal cell carcinoma and inferior vena cava tumor thrombus achieved a 5-year cancer-specific survival of 33.1%.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: